Compare Freshworks Inc (FRSH) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Freshworks Inc vs Tilray Brands Inc — how do they compare? Freshworks Inc trades at $13.92 (market cap $3.56B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: Freshworks Inc is far larger — about 6.7× Tilray Brands Inc's market cap, and Freshworks Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Freshworks Inc for 39 Days and Tilray Brands Inc for 31 Days on average.
| FRSH | TLRY | |
|---|---|---|
Market Cap | $3.56B | $530.54M |
Volume | 9,066,454 | 9,099,075 |
Sector | Technology | Health |
52-Week High | $13.92 | $21.00 |
52-Week Low | $6.88 | $3.57 |
Typical Hold Time | 39 Days | 31 Days |
Enterprise Value | $2.93B | $684.46M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Freshworks (FRSH) trades at $13.64, up 0.29% on the day, with a bullish technical signal and strong fundamental momentum. The company achieved its first quarter of GAAP profitability in Q2 2026, beating earnings expectations with $0.17 EPS versus $0.13 expected. Revenue growth remains robust at 16% year-over-year, supported by a high gross margin of 84.96%. Analyst sentiment is evenly split between Buy and Hold, with a consensus price target of $14.60.
The outlook for FRSH is positive, driven by sustained revenue growth, improving profitability, and strategic focus on AI and enterprise solutions. Key risks include competitive pressures in the SaaS sector and execution challenges in maintaining growth momentum. The stock presents an opportunity for upside relative to the consensus target, but investors should monitor quarterly execution against elevated expectations.
TLRY trades at $3.54, down 4.71% on the day and near 52-week lows, reflecting persistent bearish sentiment. The stock shows negative technical momentum with consecutive earnings misses and widening losses despite revenue growth. Recent financials reveal a net loss of $2.19B for 2025, though analyst consensus maintains a $65.01 price target with 25% buy ratings. Business developments include new product launches and leadership changes under Tilray's expanded beverage portfolio.
Outlook remains challenged by profitability concerns and high debt, but potential cannabis regulatory shifts could catalyze recovery. Investment opportunity hinges on execution improvement and market expansion, while risks include sustained cash burn and competitive pressures in the cannabis sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Freshworks Inc
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CX and ITSM categories, and have also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and better serve their customers and employees.
Read more on FRSH →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
